Piper Sandler Companies (PIPR) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the company has shown strong financial performance in the latest quarter and has positive long-term M&A prospects, the lack of recent positive trading signals, neutral hedge fund and insider activity, and mixed analyst ratings suggest a wait-and-see approach is more prudent. Additionally, the options data indicates bearish sentiment in the short term, and technical indicators do not strongly support a buy decision.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 60.201, and moving averages are converging, suggesting no strong directional trend. The stock is trading near its first resistance level (R1: 76.572), which may limit immediate upside potential.

Strong Q4 financial performance with YoY revenue growth of 37.90%, net income growth of 65.03%, and EPS growth of 65.80%. Analysts see long-term potential in M&A activity, with the cycle viewed as still in its middle stages.
No recent news or significant trading trends from hedge funds or insiders. Analyst ratings are mixed, with some downgrades and reduced price targets. Options data reflects bearish sentiment, and technical indicators do not provide a clear buy signal.
In Q4 2025, Piper Sandler reported strong financial growth: Revenue increased to $662.04M (up 37.90% YoY), Net Income rose to $113.97M (up 65.03% YoY), and EPS increased to 6.4 (up 65.80% YoY). Gross Margin improved slightly to 99.86%.
Analyst ratings are mixed. Goldman Sachs lowered the price target to $392 from $461 but maintained a Buy rating. Northland upgraded the stock to Outperform with a $350 price target, citing an inflection point in the advisory business. BofA raised its price target to $395 but maintained an Underperform rating, citing limited EPS growth potential compared to peers. Wolfe Research raised its price target to $398 and kept an Outperform rating.